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Abstract
The majority of Staphylococcus aureus virulence- and colonization-associated surface proteins contain a pentapeptide
recognition motif (LPXTG). This motif can be recognized and cleaved by sortase A (SrtA) which is a membrane-bound
transpeptidase. After cleavage these proteins are covalently incorporated into the peptidoglycan. Therefore, SrtA plays a key
role in S. aureus virulence. We aimed to generate a substrate mimicking this SrtA recognition motif for several purposes: to
incorporate this substrate into the S. aureus cell-wall in a SrtA-dependent manner, to characterize this incorporation and to
determine the effect of substrate incorporation on the incorporation of native SrtA-dependent cell-surface-associated
proteins. We synthesized substrate containing the specific LPXTG motif, LPETG. As a negative control we used a scrambled
version of this substrate, EGTLP and a S. aureus srtA knockout strain. Both substrates contained a fluorescence label for
detection by FACScan and fluorescence microscope. A spreading assay and a competitive Luminex assay were used to
determine the effect of substrate treatment on native LPXTG containing proteins deposition in the bacterial cell-wall. We
demonstrate a SrtA-dependent covalent incorporation of the LPETG-containing substrate in wild type S. aureus strains and
several other Gram-positive bacterial species. LPETG-containing substrate incorporation in S. aureus was growth phase-
dependent and peaked at the stationary phase. This incorporation negatively correlated with srtA mRNA expression.
Exogenous addition of the artificial substrate did not result in a decreased expression of native SrtA substrates (e.g.
clumping factor A/B and protein A) nor induced a srtA knockout phenotype.
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Introduction
Staphylococcus aureus is a Gram-positive pathogen that is the
leading cause of skin, soft tissue, lower respiratory tract and
bloodstream infections [1]. Its emerging multiple resistance to
antibiotic treatment is becoming a major public health concern
[2,3]. Multiple resistant S. aureus strains, such as MRSA
(methicillin resistant S. aureus), have become endemic in many
parts of the world [4]. Vancomycin is the last therapeutic option
available to treat S. aureus multi-drug resistant (MDR) infections.
Therefore, the finding of the vanA gene, encoding vancomycin
resistance, in S. aureus is worrisome [3]. So far, alternative
therapeutic and preventive measures, such as anti-staphylococcal
vaccines have not been successful [5]. The need for new
therapeutics with different modes of action is considered urgent.
S. aureus expresses a broad spectrum of secreted and cell-surface-
associated proteins during infection [1,6–8]. These cell-surface-
associated proteins are thought to play an important role during
infections by facilitating adhesion to the host factors [9,10]. The
cell-surface-associated proteins are synthesized in the cytoplasm as
precursors containing a unique N-terminal signal and a C-
terminal sorting signal with a conserved recognition pentapeptide
LPXTG motif [11,12]. The N-terminus of the precursor peptide
mediates secretion [13]. The peptide precursor can then be
recognized by means of the LPXTG motif by sortase A (SrtA), a
transpeptidase which catalyses the cleavage between the threonine
and the glycine within the recognition motif [14]. The resulting
free carboxyl group of threonine forms an amide bond with the
free amino group of the pentaglycine within the peptidoglycan
layer, leading to covalent anchoring into the staphylococcal cell-
wall [15]. This cell-surface-associated protein anchoring can be
inhibited by hydroxylamine [16]. This inhibition results in a
release of these cell-surface-associated proteins into the medium.
Nelson et al [17] already previously synthesized a SrtA pseudo-
substrate, containing an LPETG pentapeptide recognition motif.
They showed a covalent incorporation into the cell-wall of S. aureus
of this pseudo-substrate [17]. Based on their results, we generated
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a pseudo-substrate equipped with the LPETG motif as well. We
aimed to characterize the incorporation of the pseudo-substrate
into the cell-wall in a SrtA-dependent manner and to determine
the effect of pseudo-substrate incorporation on the incorporation
of native SrtA-dependent cell-surface-associated proteins. We
found that the LPETG-containing substrate incorporation takes
place in a growth phase dependent manner and peaks at the
stationary growth phase. Furthermore, the treatment of S. aureus
bacteria with the substrate alone did neither affect the deposition
of the native LPXTG containing surface proteins nor induced the
srtA KO phenotype.
Materials and Methods
Peptide Synthesis Procedure
FITC-labelled peptides were generated by solid-phase peptide
synthesis using Fmoc-chemistry with a multi-peptide synthesiser
(Syro II, MultiSynTech GmbH, Witten, Germany). Purification
by RP-HPLC and confirmation of authenticity were performed as
previously described [18]. Since the presence of a carboxylic acid
group at the C-terminus of the sortase recognition motif (LPXTG)
may inhibit SrtA activity, an amide group was incorporated at this
position [19]. FITC-labelling was achieved by incorporating a
fluorescein-containing lysine at the N-terminus of the LPXTG-
amide. More detailed description of the peptide synthesis
procedure and the chemical structure has been described
elsewhere [17]. The substrates used in this study are shown in
Table 1.
Bacterial Strains
S. aureus 8325-4 wild type (WT) strain and its isogenic srtA
deletion mutant (srtA KO) were used. This mutant was generated
by srtA:ermC allele transduction with phage w80a into S. aureus
8325-4 WT from S. aureus SH1000 srtA KO [20]. The 8325-4 srtA
KO strain was selected on erythromycin plates (3 mg/ml). The
absence of the intact srtA gene was confirmed with ermC and
flanking srtA region PCR [20]. Beside 8325-4 WT we studied the
Newman strain, a vancomycin intermediate S. aureus clinical isolate
from Erasmus MC (VISA), a selection of bloodstream isolates
obtained from Erasmus MC (B1, B4, B6 and B13), a selection of
osteomyelitis isolates obtained from Erasmus MC (O1, O2, O3
and O4) and a selection of MRSA strains (N315, MU50, COL,
BK2464, ANS46, HDE288, MW2, WIS, a pig isolate from a
Dutch slaughterhouse, and a clinical MRSA isolate from
Indonesia) [21]. Additionally, we studied a sarA (ALC 136) 8325-
4 S. aureus KO strain, which was selected on erythromycin plates as
well (3 mg/ml). Finally, we studied a selection of the Gram-positive
clinical isolates: Enterococcus faecium (E. faecium) strains with none,
VanA or VanB resistance pattern, Streptococcus agalactiae (S.
agalactiae), Staphylococcus cohnii (S. cohnii) and Enterococcus faecalis (E.
faecalis). The Gram-positive strains were all clinical isolates derived
from the EU FP7 TEMPOtest-QC project (FP7-241742), except S.
cohnii, which was an Erasmus MC bloodstream isolate.
Growth Conditions
8325-4 WT and its isogenic srtA KO strain were grown
overnight on respectively brain-heart infusion agar (BHA) (BD,
Difco, Etten-Leur, the Netherlands) and BHA supplemented with
3 mg/ml erythromycin (Abbott Laboratories, U.S.). Subsequently,
bacteria were re-suspended in Luria-Bertani (LB) (BD, Difco,
Etten-Leur, the Netherlands) medium to obtain an optical density
OD600 nm of 0.1 and supplemented with either i) medium, ii)
K(FITC)LPETG-amide or iii) a scrambled version of K(FITC)L-
PETG-amide: (K(FITC)EGTLP-amide). The final substrate con-
centration was 1 mM (unless otherwise indicated). The cultures
were normalized to OD600 nm 0.05 and cultured in a final volume
of 50 ml in 96 wells-plates. The plates were incubated until either i)
exponential (OD600 nm 0.5), ii) post-logarithmic (OD600 nm 1), iii)
stationary (OD600 nm 1.2) or iv) late stationary phase (24 hrs
incubation) in the dark at 37uC upon continuous shaking
(230 rpm). To study the substrate incorporation in Gram-positive
isolates (other than S. aureus), the bacteria were re-suspended in
Tryptic Soy Broth (TSB) (BD, BBL, Etten-Leur, the Netherlands)
medium to obtain an optical density OD600 nm of 0.1 and
supplemented with either i) medium, ii) K(FITC)LPETG-amide or
iii) a scrambled version of K(FITC)LPETG-amide: (K(FIT-
C)EGTLP-amide) and incubated during 24 hrs.
To characterise the SrtA activity more in detail, 8325-4 WT,
Newman, O1, B4, N315 and srtA KO S. aureus 8325-4 strains were
incubated after normalization (OD600 nm 0.05) in LB medium until
the previously mentioned growth phases in the absence of
substrate. Subsequently, bacterial densities were normalized to
OD600 nm 0.5 and after 3 PBS washes incubated with either i) SrtA
buffer (50 mM Tris, 150 mM NaCl, 10 mM CaCl2, pH 7.5), ii)
K(FITC)LPETG-amide in SrtA buffer or iii) a scrambled version
of K(FITC)LPETG-amide in SrtA buffer in a final volume of 50 ml
in 96 wells-plates during 1 hour in the dark at 37uC upon
continuous shaking (230 rpm). The final substrate concentration
was 1 mM.
To determine the effect of the hydroxylamine on the substrate
incorporation, 8325-4 WT and srtA KO S. aureus 8325-4 were
grown to stationary phase, washed 3 times with PBS, normalized
(OD600 nm 0.5) and incubated either with SrtA buffer or substrate
dissolved in SrtA buffer as mentioned above. Additionally, serial
dilutions (0, 5, 10, 50 and 100 mM) of NH2OH (hydroxylamine
hydrochloride, Sigma-Aldrich Zwijndrecht, the Netherlands) were
added and the plate was incubated overnight in the dark at 37uC
upon continuous shaking (230 rpm).
The bacteria were washed four times with PBS followed by
centrifugation during 5 min at 3,7006 g. To remove the non-
covalently bound and intracellular substrate, bacteria were washed
with 1% of sodium dodecyl sulphate (SDS) (Merck-Schuchardt
OHG, Germany) at 60uC during 5 min. Subsequently, bacteria
were washed again with PBS four times followed by centrifugation
Table 1. Substrates used in this study.
Substrate name Amino acids sequence
Native LPETG K(FITC)LPETG-amide
Scrambled LPETG K(FITC)EGTLP-amide
doi:10.1371/journal.pone.0089260.t001
Table 2. Oligonucleotide primers used in this study [39].
Target
gene
GenBank
accession no. Primer Primer sequence, 39R59
gyrB D10489 GyrB F TTAGTGTGGGAAATTGTCG
GyrB R AGTCTTGTGACAATGCGTT
srtA AF162687 SrtA F CGATTAATGACAATCGCT
SrtA R TAATTGTTCAGGTGTTGCTG
doi:10.1371/journal.pone.0089260.t002
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for 5 min at 3,7006 g. Pelleted bacteria were re-suspended and
used for microscopy and flow-cytometry.
Fluorescence Microscopy and Flow-cytometry
Labelled bacteria were re-suspended in PBS and analysed with
a phase contrast fluorescence microscope (Olympus IX51, Leiden,
the Netherlands). For the flow-cytometry, labelled bacteria were
re-suspended in 100 ml of 4% formaldehyde (Sigma-Aldrich,
Zwijndrecht, the Netherlands) in PBS and incubated for 45 min at
ambient temperature under continuous agitation. After 3 washes
with PBS, bacteria were re-suspended in 0.5 ml PBS. Stained
bacteria were acquired on a FacsCanto IITM flow cytometer and
analysed using FacsDivaTM software (BD Biosciences). All
FACScan analysis were performed as three independent experi-
ments. The SEM was calculated from these triplicates.
RNA Isolation
Two representative strains (O1 and 8325-4 WT) were used for
RNA isolation. Bacteria were cultured until exponential, post-
logarithmic, stationary and late stationary phase (based on OD
measurement) in LB medium as previously described. Subse-
quently, 10 ml of each bacterial culture was centrifuged at
3,7006 g during 5 min at 4uC. The pellet was re-suspended in
3.3 ml RNA protectTM Bacterial Reagents (Qiagen, Germantown,
MD, USA) and left to stabilize for 5 min at ambient temperature.
The bacteria were collected by centrifugation at 3,7006 g during
10 min at ambient temperature. The pellet was re-suspended in
1 ml RNA-pro solution (Fast RNA Pro Blue kit from MP
Biomedicals, Qbiogene Inc., City, CA, USA) and stored at 2
20uC until use. RNA was isolated according the manufacturer’s
protocol (Fast RNA Pro Blue kit from MP Biomedicals).
Reverse Transcription and Quantitative Real Time-PCR
Samples were treated with DNAase to remove the DNA
contamination from the RNA samples. We added 6 ml 10x Turbo
DNase buffer (Ambion, Austin, TX, USA) together with 2 U
Turbo DNAse (Ambion, Austin, TX, USA) to 10 mg of RNA in
DEPC-treated water (Ambion, Austin, TX, USA) and incubated
30 min at 37uC in a final volume of 60 ml in DEPC-treated water.
After 30 min of incubation, 2 U of new Turbo DNase was added
and incubation proceeded for another 30 min at 37uC. The
reaction was stopped by addition of 0.2 volumes of DNAse
inactivation reagent (Ambion, Austin, TX, USA) during 2 min at
ambient temperature and with occasional mixing. RNA contain-
ing supernatants were collected by centrifugation during 1.5 min
at 9,0006 g at ambient temperature. To remove all DNA
remnants, 2 mg of each Ambion DNase treated RNA samples
were incubated 30 min at 37uC with 2 U of DNase (Fermentas, St.
Leon-Rot, Germany) with 2 ml of reaction buffer with MgCl2 in a
final volume of 20 ml (in DEPC-treated water). The reaction was
stopped by addition of 2 ml of 25 mM EDTA (Fermentas, St.
Leon-Rot, Germany) and 10 min incubation at 65uC followed.
1 mg of total mRNA was reverse transcribed into cDNA using
200 U RevertAid H Minus Reverse transcriptase (Fermentas, St.
Leon-Rot, Germany), 4 ml of 5x reaction buffer (Fermentas, St.
Leon-Rot, Germany), 1 ml of random hexamer primers (Fermen-
tas, St. Leon-Rot, Germany), 20 U of RiboLock RNase inhibitor
(Fermentas, St. Leon-Rot, Germany) and 2 ml of 10 mM dNTP
mix (Fermentas, St. Leon-Rot, Germany) in a final volume of
20 ml. The reaction was performed according to the instructions of
the Reverse transcriptase manufacturer (Fermentas, St. Leon-Rot,
Germany). cDNA samples were diluted 1:10 and stored at 220uC
until use.
Quantitative real time PCR was carried out using the Light
Cycler instrument (Roche, Woerden, the Netherlands) in combi-
nation with the Light Cycler DNA amplification kit SYBR Green I
(Roche, Woerden, the Netherlands). Master mixes were prepared
according to the manufacturer’s instructions using target-specific
primers (listed in table 2). We performed the amplification reaction
at conditions described earlier with a modified annealing
temperature of 58uC [22]. The srtA mRNA expression was
normalized to the gyrB mRNA expression and quantified by
relative expression assays (delta/delta CT method). The specificity
of the PCR was verified by ethidium bromide staining of 2%
agarose gels after gel electrophoresis of the reaction product.
S. aureus Fibrinogen and Fc-region Binding
S. aureus 8325-4 WT and srtA KO strains were grown until
exponential growth phase (OD600 nm 0.5) in LB and Brain Heart
Infusion (BHI) (BD, Difco, Etten-Leur, the Netherlands) media in
the presence of either K(FITC)LPETG-amide or K(FIT-
C)EGTLP-amide substrates. After 3 PBS washes, bacteria were
incubated with fluorescently labelled fibrinogen (DyLight 633
NHS Esther, Thermo Scientific, Landsmeer, the Netherlands) or
with a 1/100 dilution of fluorescently labelled (DyLight 633 NHS
Esther, Thermo Scientific, Landsmeer, the Netherlands) human
IgG Fc protein (Fitzgerald Industries International, Bio-Connect
BV, Huissen, the Netherlands) in a volume of 10 ml, during 1 hr
and upon continuous agitation at ambient temperature in the
dark. Fibrinogen and IgG Fc protein labelling was performed
according to the manufacturer’s protocol. The bacteria were
washed 3 times with PBS and their fluorescence was determined
on a FacsCanto IITM flow cytometer and analysed using
FacsDivaTM software (BD Biosciences).
Semi-quantification of S. aureus Cell-surface-associated
Proteins Upon Substrate Incubation by a Competitive
Luminex
8325-4 WT and srtA S. aureus KO strains OD600 nm 0.05 were
cultured until exponential growth phase in BHI medium upon
addition of either i) medium, ii) K(FITC)LPETG-amide or iii)
K(FITC)EGTLP-amide (final volume of 200 ml), the final
substrate concentration was 1 mM. The cultures were centrifuged
at 3,7006 g at 4uC during 5 min. The bacterial pellet was
additionally washed three times with PBS. After the last wash-step,
the bacterial pellet was re-suspended in 140 ml assay buffer (PBS,
1% bovine serum albumin, 0.5% sodium azide, pH 7.4) and
tenfold serial dilution were made. To determine the effect of
substrate treatment on the covalent binding of native cell-surface-
associated proteins, other series of bacterial pellets were treated
with 1% SDS in PBS (Merck-Schuchardt) at 60uC during 5 min.
The SDS-treated pellet was washed three times with PBS and
tenfold serial dilutions were made as well. 100 ml of the bacterial
pellet dilutions were separately incubated with 100 ml 1/100
diluted HPS (human pooled serum) upon continuous shaking
800 rpm, at 4uC during 35 min (thermomixer plate shaker,
Eppendorf). The samples were centrifuged at 2,4006 g during
10 min after the incubation with HPS. 80 ml of the bacterial cell-
pellet-derived supernatant was carefully collected. These superna-
tants were centrifuged at 2,4006 g during 15 min. 60 ml of second
supernatants were stored at 4uC until use. The levels of the non-
captured S. aureus cell-surface-associated protein antibodies were
simultaneously quantified in the supernatants using Luminex bead
based flow cytometry (Luminex Corporation). Antigens used in
this assay were clumping factors A/B (ClfA and ClfB), iron-
regulated surface determinant A (IsdA), S. aureus alpha-toxin (a-
LPETG Substrate Incorporation Characterisation
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Figure 1. Native LPETG substrate is incorporated in large quantities in a SrtA-dependent manner into the S. aureus 8325-4 WT cell-
wall and incorporation can be inhibited by hydroxylamine. The S. aureus 8325-4 WT and srtA KO strains were cultured in the presence of
LPETG Substrate Incorporation Characterisation
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tox), S. pneumoniae choline-binding protein A (CbpA) and human
Metapneumovirus (hMPV-99). All antigens were coupled to
SeroMAP carboxylated beads (Luminex Corporation) as described
previously [23,24]. The final concentration of the beads was
adjusted to 3,000 beads/ml and the beads were stored until use at
4uC in the dark. a-tox (not expressed during the exponential
growth phase) and the non-S. aureus proteins (CbpA and hMPV-
99) were used as negative controls. More detailed description of
the competitive Luminex assay are described elsewhere [25].
Colony Spreading Assay
A colony spreading assay was performed as previously described
by Kaito et al and Tsompanidou et al, who showed a hyper-
spreading phenotype of srtA KO strain [26,27]. In brief, Tryptic
Soy Broth (TSB) (BD, BBL, Etten-Leur, the Netherlands) was
supplemented with 0.24% Agar powder (BD, Difco, Etten-Leur,
the Netherlands) to prepare TSA soft agar. Fifteen ml TSA soft
agar was poured into plates with 8 cm diameter and dried for
20 min. In parallel, SH1000 WT and isogenic srtA S. aureus KO
strains OD600 nm 0.05 were cultured during 24 hrs in TSB
medium upon addition of either i) medium, ii) K(FITC)LPETG-
amide or iii) K(FITC)EGTLP-amide (final volume of 50 ml), the
final substrate concentration was 2 mM, 1 mM and 0.5 mM.
After 24 hrs incubation 2 ml of individual cultures were gently
spotted on the TSA soft agar plates and dried for 15 min. The
plates were incubated during 20 hrs at 37uC. After incubation the
spreading zones were examined and pictures were taken.
Statistical Methods
Statistical analysis was performed with the Prism 5.0 package
(GraphPad software, San Diego, CA, USA). We used non-
parametric Mann Whitney testing, one-way ANOVA testing with
Bonferroni correction and Pearson correlation testing, considering
P,0.05 as being statistically significant in all cases.
Results
An Exogenous Native LPETG Substrate is in a SrtA-
dependent Manner Covalently Incorporated Into the
Cell-wall of S. aureus WT Strains
To study the substrate incorporation, we incubated S. aureus
bacteria with either K(FITC)LPETG-amide (native LPETG) or
K(FITC)EGTLP-amide (scrambled LPETG) in LB medium until
the late stationary phase. After the incubation, we treated the
bacteria with 1% SDS to remove non-covalently (a-specifically)
bound and internalized substrate. The microscopic analysis of the
8325-4 WT strain cultured with native LPETG substrate displayed
strong cell-wall-associated fluorescence (Fig. 1b and e). Neither
control experiments with medium alone (Fig. 1a and d), nor with
the scrambled version of the peptide showed detectable cellular
fluorescence (Fig. 1c and f). Furthermore, the srtA KO strain
displayed virtually no fluorescence when cultured in the presence
of native LPETG substrate (Fig. 1 h and k). The fluorescence data
therefore demonstrate that the SrtA specific substrate is incorpo-
rated into the cell-wall of S. aureus WT strain in a SrtA-dependent
manner. Culturing of bacteria in the presence of these sortase
substrates did not affect bacterial growth and viability (data not
shown). Finally, the incorporated native LPETG substrate
localizes predominantly to the bacterial perimeter in the S. aureus
cell-wall (Fig. 1 m).
To quantify the substrate incorporation, we analysed 8325-4
WT and the KO bacteria with the FACScan (Fig. 1B). WT
bacteria incubated with native LPETG substrate showed high
fluorescence, whereas srtA KO bacteria showed no significant
increase in fluorescence. Incubation with the scrambled substrate
did result in increased fluorescence in neither of the two strains
(Fig. 1B). To further explore the role of SrtA, incorporation of
external sortase substrate was tested in the presence of hydrox-
ylamine, which acts as a soluble acceptor for SrtA [16]. In the
presence of hydroxylamine, a dose-dependent inhibition of the
native LPETG substrate incorporation into the cell-wall of S. aureus
8325-4 WT strain occurred (Fig. 1C). These data all together
conclusively show that the exogenous native LPETG substrate is
efficiently processed by the endogenous S. aureus SrtA.
To determine if strains other than S. aureus 8325-4 WT can
incorporate the native LPETG substrate, 10 MSSA and 10 MRSA
strains were analysed. All tested S. aureus strains showed only
incorporation of the native LPETG substrate (Fig. 2A). Strain-
specific differences in incorporation rates were observed. As SrtA
transpeptidase is widely distributed among Gram-positive bacteria,
we incubated a selection of Gram-positive clinical isolates with the
native LPETG substrate [28,29]. S. agalactiae, E. faecalis and S.
cohnii showed no incorporation of the native LPETG substrate.
The VISA strain incorporated native LPETG substrate compa-
rably to 8325-4 WT strain. Two out of the three tested E. faecium
strains incorporated the native LPETG substrate, in particularly
the vanB positive strain incorporated high levels of the SrtA specific
substrate (Fig. 2B).
The Incorporation of the Native LPETG Substrate in S.
aureus Strains is Growth-phase Dependent and Peaks at
the Stationary Growth Phase
We wondered whether SrtA is capable to incorporate the native
LPETG substrate during the different growth phases. We cultured
8325-4 WT S. aureus strain in the presence of the native or
scrambled LPETG substrates until exponential, post-logarithmic,
stationary or late stationary phase, and quantified the substrate
incorporation using FACS. A time dependent progressive accu-
mulation of native LPETG in the cell-wall was observed (r = 0.99),
suggesting that in each growth phase SrtA is active (Fig. 3A). To
explore the S. aureus SrtA activity in these growth phases in greater
detail, different S. aureus strains were cultured in the absence of the
substrate until they had reached a specific growth phase. The
bacteria were harvested, and then incubated with native LPETG
1 mM native or scrambled LPETG substrates in LB medium during 24 hrs. Bacteria were washed, re-suspended in PBS and analysed with (A)
fluorescence microscopy and (B) FACS. Abbreviations: WT: wild type S. aureus (8325-4), srtA KO (isogenic srtA deletion mutant), merge: fluorescent
images superimposed on top of brightfield images, fluorescence: fluorescence images, medium: bacteria incubated only in LB medium, native LPETG:
bacteria incubated with 1 mM K(FITC)LPETG-amide substrate diluted in LB medium, scrambled LPETG: bacteria incubated with 1 mM K(FITC)EGTLP-
amide substrate diluted in LB medium. The microscopy images are a representation of at least 5 independent experiments. The histogram of FACS
data represents the FITC fluorescence intensity on the x-axis and the bacterial count on the y-axis. FACS scan analysis is a representation of 3
independent experiments. (C) Effect of hydroxylamine on native LPETG incorporation. Bacteria were grown until stationary growth phase was
reached, washed, normalized to OD600 nm 0.5 and incubated overnight with 1 mM native or scrambled LPETG substrates in SrtA buffer upon addition
of 0, 5, 10, 50 or 100 mM of NH2OH. After incubation, bacteria were analysed by FACS. The mean fluorescence intensity, reflecting the quantity of the
incorporated substrate per bacteria, was plotted on the y-axis. This is a representative image of independently performed FACS analysis in triplicate
with the SEM depicted.
doi:10.1371/journal.pone.0089260.g001
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Figure 2. Several S. aureus and other Gram-positive strains incorporate different levels of native LPETG substrate after 24 hrs of
incubation. (A) FACS analysis of 10 MSSA and 10 MRSA S. aureus isolates. All S. aureus strains were incubated in LB medium as described in figure 1A.
(B) FACS analysis of a selection of Gram positive bacteria. The bacteria were cultured in the presence of 1 mM native or scrambled LPETG substrates
during 24 hrs in TSB medium. Bacteria were washed, re-suspended in PBS and analysed with FACS. Bacterial strains used are depicted on the x-axis.
Abbreviations used are described in figure 1. These are the representative images of independently performed FACS analysis in triplicate with the
SEM depicted.
doi:10.1371/journal.pone.0089260.g002
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Figure 3. The SrtA-specific native LPETG substrate incorporation in 8325-4 WT bacteria occurs in a cumulative manner, is growth
phase-dependent and negatively correlates to the srtA mRNA expression. (A) Native LPETG substrate incorporation during different
bacterial growth phases. S. aureus 8325-4 WT and srtA KO were grown until different growth phases (exp: exponential, post log: post-logarithmic, stat:
stationary or late stationary) in the presence of 1 mM native or scrambled LPETG substrates. Bacteria were harvested at several time points depicted
on the x-axis. The mean fluorescence intensity is depicted on the y-axis. (B) Determination of the SrtA activity towards the native LPETG substrate in S.
aureus bacteria in different bacterial growth phases. Five WT S. aureus strains and one S. aureus srtA KO strain were cultured in LB medium in the
absence of the substrate until exponential, post-logarithmic, stationary or late stationary phase. Normalized bacteria to OD600 nm 0.5 were incubated
with the native or scrambled LPETG substrate in SrtA buffer during 1 hr. The bacteria were analysed with FACS after several PBS washes. Bacteria
tested are depicted on the x-axis and the mean fluorescence intensity is depicted on the y-axis. We used one-way ANOVA testing with Bonferroni
correction to analyse statistical differences. (C) Determination of the srtA expression during different growth phases. 8325-4 WT and O1 S. aureus
strains were cultured until the previously mentioned growth phases at which mRNA was isolated. The time points at which the bacteria were
harvested are plotted on the x-axis. The mean fluorescence reflecting the native LPETG substrate incorporation in the corresponding strains was
plotted for the comparison on the right y-axis. The mRNA transcripts are depicted on the left y-axis. srtA transcripts were quantified and compared to
the transcription of gyrB.
doi:10.1371/journal.pone.0089260.g003
Figure 4. Fibrinogen and IgG Fc region binding to S. aureus bacteria is not specifically influenced by the native LPETG substrate
incorporation. S. aureus 8325-4 WT and srtA KO strains were grown until exponential growth phase in LB and BHI medium in the presence of the
native or scrambled LPETG substrates. After 3 PBS washes, the bacteria were incubated with fluorescently labelled (A) IgG Fc region or (B) fibrinogen.
The IgG Fc region and fibrinogen binding was analysed with FACS. The conditions tested are depicted under the graphs. The mean fluorescence
intensity is depicted on the y-axis.
doi:10.1371/journal.pone.0089260.g004
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for one hour. Incorporation of native LPETG was subsequently
measured by FACS. In all tested strains, the incorporation rate
was lowest at the exponential phase, intermediate during the post-
logarithmic phase, and in the majority of the strains peaked at the
stationary phase (in 4 out of the 5 tested strains, the incorporation
rate was two times higher in this phase than in the exponential
phase), and decreased in the late stationary phase (Fig. 3B).
In order to determine whether the increased SrtA activity in
stationary phase bacteria was due to the increased expression of
sortase A, transcription of srtA was measured in two representative
strains (8325-4 WT and O1) during the various bacterial growth
phases. The overall srtA expression was higher in the clinical
isolate (O1) compared to the laboratory strain 8325-4 WT. This is
in line with the observation that O1 strain shows an increased
incorporation of the native LPETG substrate in comparison to
8325-4 WT (Fig. 3C). In both strains srtA mRNA expression
peaked during the exponential growth phase and then decreased
over time in a growth phase-dependent manner (Fig. 3C). Overall,
srtA mRNA expression negatively correlated to the native LPETG
substrate incorporation rate (r =20.70 for 8325-4 WT strain and
r =20.54 for O1 strain).
Native LPETG Substrate Incorporation in S. aureus 8325-4
WT Strain Does not Affect Incorporation of Physiological
SrtA Substrates
To determine whether exogenous native LPETG substrate
competes with the native SrtA-dependent cell-surface-associated
proteins on the S. aureus 8325-4 WT surface, bacteria were grown
in the presence of native LPETG in different media until
exponential growth phase. Fibrinogen and Fc binding properties
were subsequently measured with FACS. No specific alternations
in the levels of fibrinogen and IgG Fc region binding to 8325-4
WT were observed, neither in BHI nor in LB medium (Fig. 4A–B).
Furthermore, no decrease in surface exposition of the physiological
SrtA substrates ClfA, ClfB and IsdA occurred, as measured by a
competitive Luminex assay (Fig. 5A–C). Finally, we examined if
culturing in the presence of native LPETG would induce a SrtA
KO hyper-spreading phenotype. Culturing S. aureus strain in the
presence of the native LPETG substrate, did not lead to the
induction of such a phenotype (Fig. 6).
Discussion
Nelson et al previously demonstrated that S. aureus endogenous
SrtA is accessible for exogenous LPETG-containing substrate and,
as such, is capable of incorporating this substrate covalently in a
SrtA-dependent manner into the bacterial cell-wall [17]. We have
confirmed these data with three independent in vitro experiments.
The native LPETG substrate incorporation occurred despite the
production of the native SrtA-dependent cell-surface-associated
proteins. The native LPETG substrate incorporation occurred in
the absence of the positively charged region and the hydrophobic
part naturally occurring on the C-terminus of the SrtA-dependent
cell-surface-associated proteins. Our data and the data of Nelson
et al, therefore, do not support the data of Schneewind et al who
found C-terminal hydrophobic domain and the positively charged
tail of the transmembrane domain to be critical for the successful
covalent incorporation of SrtA-dependent cell-surface-associated
proteins into the peptidoglycan layer of living S. aureus bacteria
[11]. This suggests that the C-terminal hydrophobic domain and
the positively charged tail are only essential for endogenous cell-
surface-associated proteins incorporation exported from the
cytoplasm.
Besides S. aureus, a selection of Gram-positive clinical isolates
incorporated the native LPETG substrate as well. This might be a
consequence of the fact that SrtA transpeptidase is widely
distributed among Gram-positive bacteria [29].
From our experiments we conclude that endogenous S. aureus
SrtA incorporates most native LPETG substrate during stationary
growth. We hypothesised that S. aureus may possess more available
SrtA in the stationary phase due to competition of cell-surface-
associated proteins during other growth phases, in particular the
exponential phase, where the highest srtA expression occurs [30].
To support this hypothesis, we studied a sarA mutant. The sarA
locus is responsible for the regulation of the production of many
cell-surface-associated proteins [31,32]. We found no difference in
the ability of the sarA mutant to incorporate the native LPETG
substrate in comparison to a 8325-4 WT strain. This finding
suggests that the cell-surface-associated proteins are not the
limiting factor for the native LPETG substrate incorporation
during different bacterial growth phases.
We did not find any effect on the native cell-surface-associated
proteins deposition upon native LPETG exposure. The native
LPETG substrate can be incorporated into the bacterial cell-wall
in large quantities, comparable to the native collagen binding
protein [17]. We suggest, therefore, that there are enough
accessible and free pentaglycines during all bacterial growth
phases, in particular stationary growth phase, in the bacterial cell-
wall for both the native LPETG substrate and cell-surface
associated proteins to be incorporated [33,34].
S. aureus bacteria lacking functional SrtA are attenuated in their
virulence [20,35–37]. Therefore, SrtA is an attractive target for
anti-microbial therapy. In the past, several attempts were made to
develop SrtA inhibitors [38]. However, most of these inhibitors
identified previously lack specificity, have a low specific activity or
possess non-suitable chemical characteristics such as high molec-
ular weight and undesirable pharmacological properties, which
render these inhibitors unsuitable as potential therapeutics.
Alternatively, our synthetic SrtA specific substrates might be used
as a vehicle for antibiotics or anti-microbial peptides to introduce
more specific targeting of these molecules into the bacterial cell-
wall. This specific targeting might in the future facilitate peptide-
based therapy, which is an interesting alternative on conventional
anti-bacterial treatment.
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